Screening and Early Detection
636 articles
Terms of Use
Copyright The entire content included in this Website, letswinpc.org, including but not limited to text, graphics, or code, is copyrighted as a collective work under the United States’ and other copyright laws, and is the property of Let’s Win. The collective work includes works that are licensed to Let’s Win. ALL RIGHTS RESERVED. You may […]
Handling the Changes Cancer Brings to Your Lifestyle
Drs. Sunil Hingorani and David Zhen discuss ways to handle lifestyle changes including work and diet during pancreatic cancer treatment.
Reading the Scientific Study to Understand a Pancreatic Cancer Treatment
How can you tell if a scientific study is good? Learn what to look for in reliable studies and whether there may be a trial to pursue.
My Eight-Year Un-Celebration of Surviving Pancreatic Cancer
William Ramshaw shares his thoughts and advice for those in treatment, on reaching the eight-year pancreatic cancer survivor mark.
Let’s Win Inducted into the PR News Platinum Hall of Fame
Let’s Win has been inducted into the PR News Platinum Hall of Fame. Other inductees include the ALS Association’s ice bucket challenge.
In Safe Hands: Selecting the Right Whipple Surgeon
The Whipple procedure is a complex surgery–how do you find an expert with the vast experience needed for your surgery?
Exploring Alternatives to Creon for Pancreatic Enzyme Replacement Therapy
Oncology dietitian Meghan Laszlo explains how pancreatic enzyme replacement drug Creon works and available alternatives.
What You Should Know About Tumor Boards
A tumor board brings together experts in different treatment fields to discuss your case and help direct your pancreatic cancer treatment.
Millicent Fortunoff
Millicent Fortunoff is President of M. Fortunoff Communications. She has extensive experience managing global and national media relations campaigns that build one reputation across regions, yet tailored to local issues and audiences. Prior to opening her own consultancy Ms. Fortunoff was a Senior Vice President in the Global Issues Communications Group at Ruder Finn (Finn […]
An Immunotherapy Game Changer
Immunotherapy with Keytruda (pembrolizumab) is approved for use in cancer patients with certain genetic defects in their tumors.
Let’s Win! Pancreatic Cancer Updates Clinical Trials Section
Let’s Win announces updates to its clinical trials section on its website. These include a new clinical trial finder, animations,and educational pages.